Gene therapy of neurodegenerative diseases: achievements, developments, and clinical implementation challenges
Neurodegenerative diseases (NDDs) are promising objects for the development of gene therapy products, primarily, due to the possible cause of these diseases (disruption of a gene or several genes), lack of effective therapy, and negative impact on the quality of life of both patients and their famil...
Saved in:
| Main Authors: | E. V. Melnikova, V. A. Merkulov, O. V. Merkulova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2023-06-01
|
| Series: | Биопрепараты: Профилактика, диагностика, лечение |
| Subjects: | |
| Online Access: | https://www.biopreparations.ru/jour/article/view/433 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Experience of using gene replacement therapy with Zolgensma® (onasemnogene abeparvovec) in real clinical practice in Russia
by: S. B. Artemyeva, et al.
Published: (2022-02-01) -
Gene therapy in neuromuscular disorders
by: Rodrigo Holanda Mendonça, et al.
Published: (2022-08-01) -
Recent Advance in Disease Modifying Therapies for Spinal Muscular Atrophy
by: Li-Kai Tsai, et al.
Published: (2024-07-01) -
Adult-onset non-5q proximal spinal muscular atrophy: a comprehensive review
by: Wladimir Bocca Vieira de Rezende Pinto, et al.
Published: (2021-01-01) -
Gene Therapy Medicinal Products: Non-clinical Safety Studies
by: O. V. Astapova, et al.
Published: (2023-03-01)